"10.1371_journal.pone.0075021","plos one","2013-09-19T00:00:00Z","Trygve HolmÃ¸y; Kristin Ingeleiv LÃ¸ken-Amsrud; SÃ¸ren Jacob Bakke; Antonie G Beiske; Kristian S Bjerve; Harald Hovdal; Finn LilleÃ¥s; Rune Midgard; Tom Pedersen; Jutrate Å altytÄ— Benth; Ã˜ivind Torkildsen; Stig Wergeland; Kjell-Morten Myhr; Annika E Michelsen; PÃ¥l Aukrust; Thor Ueland","Department of Neurology, Akershus University Hospital, LÃ¸renskog, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Neurology, Innlandet Hospital Trust, Lillehammer, Norway; Department of Neuroradiology, Oslo University Hospital, Oslo, Norway; Multiple Sclerosis Centre Hakadal, Hakadal, Norway; Department of Medical Biochemistry, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway; Department of Neurology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway; Curato Oslo, Oslo, Norway; Department of Neurology, Molde Hospital, Molde, Norway; Unit for Applied Clinical Research, Norwegian University of Science and Technology, Trondheim, Norway; Unilabs Drammen, Drammen, Norway; Helse SÃ¸r-Ã˜st Health Services Research Centre, Akershus University Hospital, LÃ¸renskog, Norway; Norwegian Multiple Sclerosis Competence Centre, Department of Neurology, Haukeland University Hospital, Bergen, Norway; KG Jebsen MS Research Centre, Department of Clinical Medicine, University of Bergen, Bergen, Norway; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway","Conceived and designed the experiments: TH KILA SJB AGB KSB HH FL RM TP KMM PA TU. Performed the experiments: FL TP PA TU AEM. Analyzed the data: TH JSB PA TU. Contributed reagents/materials/analysis tools: FL TP Ã˜T SW PA TU AEM. Wrote the manuscript: TH PA TU. Review of the manuscript for intellectual content: KILA Ã˜T KMM SJB AGB KSB HH FL RM TP AEM KMM PA TU.","FL is employed by Curato Oslo and Tom Pedersen by Unilabs. The study was partly supported by Merck-Serono, Pronova Biocare and Bayer Schering. KILA has received travel support and an unrestricted research grant from Biogen Idec and travel support from Merck Serono. KMM has received honoraria for lecturing, participation in pharmaceutical company sponsored clinical trials, and travel support from Bayer Schering, Biogen Idec, Novartis, Merck-Serono and Sanofi Aventis. HH has participated in pharmaceutical company sponsored clinical trials and received travel support from Merck Serono, Biogen Idec and Bayer Schering. RM has received honoraria for lecturing, participation in pharmaceutical company sponsored clinical trials, and travel support from Bayer Schering, Biogen Idec, Novartis, Merck-Serono and Sanofi Aventis. SW has received speaker honoraria and travel support from Sanofi Aventis, Biogen Idec, Bayer Schering and Novartis. TH has received speaker honoraria and travel support from Sanofi Aventis, Biogen Idec, Bayer Schering, Novartis and Merck Serono. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","09","Trygve HolmÃ¸y","THÃ",16,TRUE,12,5,4,3,TRUE,TRUE,TRUE,1,"10",FALSE
